Why the study?
What are the guideline recommendations for the pharmacologic treatment of heart failure due to left ventricular systolic dysfunction?
What are the guideline recommendations for the pharmacologic treatment of heart failure due to left ventricular systolic dysfunction?
This guideline summary establishes foundational recommendations for the pharmacologic management of heart failure with reduced ejection fraction, emphasizing ACE inhibitors as first-line therapy.
No takes yet. Share an insight, caveat, or question.
Prioritizes ACE inhibitors for eligible HFrEF patients; reinforces evidence-based pharmacologic sequencing in systolic HF.
David W. Baker (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: